2022 ICD-10-CM Diagnosis Code G92.03

Immune effector cell-associated neurotoxicity syndrome, grade 3

    2022 - New Code Billable/Specific Code
  • G92.03 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Immune effector cell-associated neurotoxicity synd, grade 3
  • ICD-10-CM G92.03 is a new 2022 ICD-10-CM code that became effective on October 1, 2021.
  • This is the American ICD-10-CM version of G92.03 - other international versions of ICD-10 G92.03 may differ.
Applicable To
  • ICANS, grade 3
The following code(s) above G92.03 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to G92.03:
  • G00-G99
    2022 ICD-10-CM Range G00-G99

    Diseases of the nervous system

    Type 2 Excludes
    • certain conditions originating in the perinatal period (P04-P96)
    • certain infectious and parasitic diseases (A00-B99)
    • complications of pregnancy, childbirth and the puerperium (O00-O9A)
    • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
    • endocrine, nutritional and metabolic diseases (E00-E88)
    • injury, poisoning and certain other consequences of external causes (S00-T88)
    • neoplasms (C00-D49)
    • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
    Diseases of the nervous system
  • G92.0
    ICD-10-CM Diagnosis Code G92.0

    Immune effector cell-associated neurotoxicity syndrome

      2022 - New Code Non-Billable/Non-Specific Code
    Code First
    • underlying cause such as:
    • complications of immune effector cellular therapy (T80.82)
    Code Also
    • associated signs and symptoms, such as seizures and cerebral edema
    Immune effector cell-associated neurotoxicity syndrome
ICD-10-CM G92.03 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
  • 023 Craniotomy with major device implant or acute complex cns principal diagnosis with mcc or chemotherapy implant or epilepsy with neurostimulator
  • 024 Craniotomy with major device implant or acute complex cns principal diagnosis without mcc
  • 091 Other disorders of nervous system with mcc
  • 092 Other disorders of nervous system with cc
  • 093 Other disorders of nervous system without cc/mcc
  • 791 Prematurity with major problems
  • 793 Full term neonate with major problems
Code History
  • 2022 (effective 10/1/2021): New code

Diagnosis Index entries containing back-references to G92.03:

ICD-10-CM Codes Adjacent To G92.03
G91.2 (Idiopathic) normal pressure hydrocephalus
G91.3 Post-traumatic hydrocephalus, unspecified
G91.4 Hydrocephalus in diseases classified elsewhere
G91.8 Other hydrocephalus
G91.9 Hydrocephalus, unspecified
G92 Toxic encephalopathy
G92.0 Immune effector cell-associated neurotoxicity syndrome
G92.00 …… grade unspecified
G92.01 …… grade 1
G92.02 …… grade 2
G92.03 …… grade 3
G92.04 …… grade 4
G92.05 …… grade 5
G92.8 Other toxic encephalopathy
G92.9 Unspecified toxic encephalopathy
G93 Other disorders of brain
G93.0 Cerebral cysts
G93.1 Anoxic brain damage, not elsewhere classified
G93.2 Benign intracranial hypertension
G93.3 Postviral fatigue syndrome
G93.4 Other and unspecified encephalopathy

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.